HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoyun Lu Selected Research

poly(3- hydroxybutyrate- co- 3- hydroxyhexanoate)

1/2019Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Biopolyester Based Nanoparticles as NVP-BEZ235 Delivery Vehicle for Tumor Targeting Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoyun Lu Research Topics

Disease

34Neoplasms (Cancer)
02/2022 - 04/2011
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 11/2013
4Inflammation (Inflammations)
01/2022 - 01/2015
4Lymphoma (Lymphomas)
11/2016 - 07/2014
3Tuberculosis (Tuberculoses)
11/2021 - 04/2010
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2018 - 02/2015
2Hypertension (High Blood Pressure)
01/2022 - 01/2021
2Glioma (Gliomas)
11/2021 - 11/2018
2Extensively Drug-Resistant Tuberculosis
11/2021 - 06/2017
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2021 - 10/2017
2Neuroblastoma
10/2019 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2019 - 11/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 01/2012
2Breast Neoplasms (Breast Cancer)
01/2019 - 01/2012
2Neoplasm Metastasis (Metastasis)
01/2019 - 05/2016
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2016 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 03/2014
1Ischemic Stroke
03/2022
1Chronic Pain
01/2022
1Carotid Artery Diseases
01/2022
1Pain (Aches)
11/2021
1Renal Cell Carcinoma (Grawitz Tumor)
11/2021
1Metabolic Diseases (Metabolic Disease)
10/2021
1Autoimmune Diseases (Autoimmune Disease)
10/2021
1Parkinson Disease (Parkinson's Disease)
06/2021
1Colonic Neoplasms (Colon Cancer)
02/2021
1Aneuploidy (Aneuploid)
02/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1Vomiting
01/2020
1Postoperative Pain
01/2020
1Dizziness (Lightheadedness)
01/2020
1Nausea
01/2020
1Autistic Disorder (Autism)
11/2019
1Hyperglycemia
11/2019
1Obesity
10/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019
1Stroke (Strokes)
01/2019
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2019
1Infarction (Infarctions)
01/2019

Drug/Important Bio-Agent (IBA)

14Phosphotransferases (Kinase)IBA
01/2022 - 04/2011
11Pharmaceutical PreparationsIBA
11/2021 - 03/2012
6Biological ProductsIBA
02/2020 - 03/2012
5ErbB Receptors (EGF Receptor)IBA
12/2022 - 03/2014
4Proteins (Proteins, Gene)FDA Link
04/2018 - 01/2012
2osimertinibIBA
02/2022 - 01/2019
2TropomyosinIBA
01/2022 - 01/2019
2Apolipoproteins E (ApoE)IBA
01/2022 - 01/2021
2ApolipoproteinsIBA
01/2022 - 01/2021
2Indicators and Reagents (Reagents)IBA
11/2021 - 01/2016
2Messenger RNA (mRNA)IBA
01/2021 - 12/2018
2Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2019 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 11/2016
2Sirtuin 1IBA
01/2019 - 12/2018
23-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
11/2018 - 10/2013
2Peptides (Polypeptides)IBA
04/2018 - 06/2017
2Gefitinib (Iressa)FDA Link
01/2018 - 11/2013
2GZD856IBA
12/2017 - 05/2016
2Therapeutic UsesIBA
01/2017 - 01/2016
1snake venom protein C activatorIBA
02/2022
1LS-106IBA
02/2022
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1LDL CholesterolIBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022
1Opioid Analgesics (Opioids)IBA
11/2021
1Levodopa (L Dopa)FDA LinkGeneric
06/2021
1Isoleucine (L-Isoleucine)FDA Link
05/2021
1Threonine (L-Threonine)FDA Link
05/2021
1Paclitaxel (Taxol)FDA LinkGeneric
02/2021
1Oxygen (Dioxygen)IBA
01/2021
1sanguinarineIBA
02/2020
1Remifentanil (Ultiva)FDA Link
01/2020
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2020
1InterleukinsIBA
01/2020
1superoxide dismutase 2IBA
11/2019
1AntioxidantsIBA
11/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2019
1Sweetening Agents (Sweeteners)IBA
10/2019
1psicose (D-psicose)IBA
10/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1ResveratrolIBA
01/2019
1Discoidin Domain Receptor 1IBA
01/2019
1pyridineIBA
01/2019
1CollagenIBA
01/2019
1CytochromesIBA
01/2019
1dactolisibIBA
01/2019
1CateninsIBA
01/2019
1poly(3- hydroxybutyrate- co- 3- hydroxyhexanoate)IBA
01/2019
1Type 4 Fibroblast Growth Factor ReceptorIBA
01/2019
15- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA
01/2019
1N-end cysteine peptide tumor-homing peptideIBA
12/2018

Therapy/Procedure

9Therapeutics
02/2021 - 03/2014
4Drug Therapy (Chemotherapy)
01/2019 - 06/2012
1Thrombectomy
03/2022
1Oral Administration
02/2022
1Nephrectomy
11/2021
1Length of Stay
01/2020
1Intravenous Administration
12/2018